Project Number CIHR-RIVEST-2013 Agency/Funding Organization Canadian Institutes of Health Research (CIHR) Funding Year 2013 View Full Project Details for Novel immunotherapies for treating Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 9. Immunity and Inflammation d. Immunotherapy - Mechanisms of Action Researcher and Organization Principal Investigator RIVEST, Serge Principal Investigator First Name Serge Principal Investigator Last Name RIVEST Awardee Organization Université Laval Contact PI Country Canada Project Detail FY Overall Cost $114,240 Funding Organization Agency/Funding Organization Canadian Institutes of Health Research (CIHR) Funding Organization Country Canada
